Table 1 Patient information and surgery-related outcomes
Variables | Total (n = 282) | Anastomosis (n = 182) | Ostomy (n = 100) | P |
|---|---|---|---|---|
Age (years) | 57 (23–83) | 55 (25–77) | 58.5 (26–83) | < 0.01 |
Body mass index (kg/m2) | 22.2 (14.2–37.3) | 22.0 (14.2–34.2) | 23.2 (16.0–37.3) | 0.10 |
Neo-adjuvant chemotherapy (%) | 49 (17.4%) | 29 (15.9%) | 20 (20.0%) | 0.39 |
Preoperative laboratory values | ||||
CA-125 (U/mL) | 1006.5 (3.5–31,803.7) | 1114.5 (3.5–31,803.7) | 907.3 (7.4–23,156.0) | 0.55 |
Albumin (g/L) | 40.0 (24.4–55.3) | 40.7 (26.9–55.3) | 39.6 (27.6–48.5) | 0.64 |
Hemoglobin (g/L) | 119 (62–151) | 119 (76–151) | 120 (62–147) | 0.87 |
Postoperative day 1 laboratory values | ||||
Albumin (g/L) | 31.0 (19.3–48.9) | 31.2 (19.9–48.9) | 30.2 (19.3–43.5) | 0.28 |
Hemoglobin (g/L) | 111 (69–159) | 111 (72–159) | 111 (69–142) | 0.16 |
High-grade serous carcinoma (%) | 250 (88.7%) | 157 (86.3%) | 93 (93.0%) | 0.09 |
Presence of ascites at surgery (%) | 222 (78.7%) | 147 (80.8%) | 75 (75.0%) | 0.26 |
Ascites volume (mL) | 800 (50–8000) | 800 (50–8000) | 1000 (50–7500) | 0.72 |
Extensive bowel resection (%) | 29 (10.2%) | 20 (11.0%) | 9 (9.0%) | 0.60 |
Upper abdominal surgery (%) | 69 (24.4%) | 57 (31.3%) | 12 (12.0%) | < 0.01 |
Extent of debulking | ||||
Residual disease = 0 cm (%) | 121 (42.9%) | 88 (48.4%) | 33 (33.0%) | 0.01 |
Residual disease ≤ 1 cm (%) | 248 (87.9%) | 166 (91.2%) | 82 (82.0%) | 0.02 |
Operation time (minutes) | 197 (60–371) | 203 (97–371) | 172 (60–324) | < 0.01 |
Estimated blood loss (ml) | 1000 (100–3500) | 950 (100–3500) | 1000 (200–2500) | 0.98 |
Transfusion (%) | 248 (87.9%) | 156 (85.7%) | 92 (92.0%) | 0.12 |
Red blood cell transfusion (unit) | 3 (0–11) | 3 (0–11) | 3 (0–9) | 0.93 |
Postoperative hospital stay (days) | 13 (5–53) | 13 (5–53) | 10 (5–40) | < 0.01 |
Time to chemotherapy (days) | 19 (7–50) | 20 (7–50) | 18 (7–41) | 0.14 |